Annual Total Assets
$12.08 M
-$9.51 M-44.07%
December 31, 2023
Summary
- As of February 8, 2025, CLRB annual total assets is $12.08 million, with the most recent change of -$9.51 million (-44.07%) on December 31, 2023.
- During the last 3 years, CLRB annual total assets has fallen by -$46.58 million (-79.41%).
- CLRB annual total assets is now -79.41% below its all-time high of $58.66 million, reached on December 31, 2020.
Performance
CLRB Total Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Assets
$37.29 M
+$7.91 M+26.91%
September 30, 2024
Summary
- As of February 8, 2025, CLRB quarterly total assets is $37.29 million, with the most recent change of +$7.91 million (+26.91%) on September 30, 2024.
- Over the past year, CLRB quarterly total assets has increased by +$25.22 million (+208.83%).
- CLRB quarterly total assets is now -36.42% below its all-time high of $58.66 million, reached on December 31, 2020.
Performance
CLRB Quarterly Total Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Assets Formula
Total Assets = Current Assets + Non-Current Assets
CLRB Total Assets Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -44.1% | +208.8% |
3 y3 years | -79.4% | -11.1% |
5 y5 years | -19.8% | +138.2% |
CLRB Total Assets Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -67.5% | at low | -13.1% | +472.9% |
5 y | 5-year | -79.4% | at low | -36.4% | +472.9% |
alltime | all time | -79.4% | +723.7% | -36.4% | >+9999.0% |
Cellectar Biosciences Total Assets History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | $37.29 M(+26.9%) |
Jun 2024 | - | $29.38 M(-31.5%) |
Mar 2024 | - | $42.91 M(+255.3%) |
Dec 2023 | $12.08 M(-44.1%) | $12.08 M(-44.0%) |
Sep 2023 | - | $21.55 M(+231.1%) |
Jun 2023 | - | $6.51 M(-56.1%) |
Mar 2023 | - | $14.84 M(-31.3%) |
Dec 2022 | $21.59 M(-42.0%) | $21.59 M(+11.8%) |
Sep 2022 | - | $19.32 M(-25.4%) |
Jun 2022 | - | $25.89 M(-19.1%) |
Mar 2022 | - | $31.99 M(-14.0%) |
Dec 2021 | $37.20 M(-36.6%) | $37.20 M(-11.3%) |
Sep 2021 | - | $41.95 M(-12.1%) |
Jun 2021 | - | $47.74 M(-13.3%) |
Mar 2021 | - | $55.06 M(-6.1%) |
Dec 2020 | $58.66 M(+378.8%) | $58.66 M(+183.4%) |
Sep 2020 | - | $20.70 M(-13.2%) |
Jun 2020 | - | $23.85 M(+174.5%) |
Mar 2020 | - | $8.69 M(-29.1%) |
Dec 2019 | $12.25 M(-18.6%) | $12.25 M(-21.8%) |
Sep 2019 | - | $15.66 M(-18.2%) |
Jun 2019 | - | $19.14 M(+52.5%) |
Mar 2019 | - | $12.55 M(-16.6%) |
Dec 2018 | $15.05 M(+17.0%) | $15.05 M(-23.0%) |
Sep 2018 | - | $19.54 M(+179.3%) |
Jun 2018 | - | $7.00 M(-26.8%) |
Mar 2018 | - | $9.56 M(-25.7%) |
Dec 2017 | $12.87 M(-16.0%) | $12.87 M(+30.4%) |
Sep 2017 | - | $9.87 M(-21.7%) |
Jun 2017 | - | $12.60 M(-17.6%) |
Mar 2017 | - | $15.30 M(-0.2%) |
Dec 2016 | $15.32 M(+101.7%) | $15.32 M(+64.9%) |
Sep 2016 | - | $9.30 M(-18.3%) |
Jun 2016 | - | $11.38 M(+104.3%) |
Mar 2016 | - | $5.57 M(-26.7%) |
Dec 2015 | $7.60 M(-43.4%) | $7.60 M(+17.6%) |
Sep 2015 | - | $6.46 M(-24.7%) |
Jun 2015 | - | $8.58 M(-21.4%) |
Mar 2015 | - | $10.91 M(-18.7%) |
Date | Annual | Quarterly |
---|---|---|
Dec 2014 | $13.42 M(+96.9%) | $13.42 M(-14.6%) |
Sep 2014 | - | $15.72 M(+167.0%) |
Jun 2014 | - | $5.89 M(-26.8%) |
Mar 2014 | - | $8.04 M(+18.0%) |
Dec 2013 | $6.82 M(-40.6%) | $6.82 M(-29.3%) |
Sep 2013 | - | $9.65 M(-20.4%) |
Jun 2013 | - | $12.13 M(-15.3%) |
Mar 2013 | - | $14.31 M(+24.7%) |
Dec 2012 | $11.48 M(+8.7%) | $11.48 M(+10.5%) |
Sep 2012 | - | $10.39 M(-12.3%) |
Jun 2012 | - | $11.85 M(+37.0%) |
Mar 2012 | - | $8.65 M(-18.1%) |
Dec 2011 | $10.56 M(+120.0%) | $10.56 M(+51.0%) |
Sep 2011 | - | $7.00 M(-17.0%) |
Jun 2011 | - | $8.43 M(+660.0%) |
Mar 2011 | - | $1.11 M(-76.9%) |
Dec 2010 | $4.80 M(-46.2%) | $4.80 M(+37.5%) |
Sep 2010 | - | $3.49 M(-0.3%) |
Jun 2010 | - | $3.50 M(-39.5%) |
Mar 2010 | - | $5.79 M(-35.1%) |
Dec 2009 | $8.93 M(+509.3%) | $8.93 M(+49.0%) |
Sep 2009 | - | $6.00 M(+28.8%) |
Jun 2009 | - | $4.66 M(-34.7%) |
Mar 2009 | - | $7.13 M(+386.4%) |
Dec 2008 | $1.47 M(-86.8%) | $1.47 M(-67.2%) |
Sep 2008 | - | $4.46 M(-22.4%) |
Jun 2008 | - | $5.75 M(-14.3%) |
Mar 2008 | - | $6.71 M(-39.5%) |
Dec 2007 | $11.11 M(-6.8%) | $11.11 M(-29.1%) |
Sep 2007 | - | $15.68 M(-23.7%) |
Jun 2007 | - | $20.54 M(+113.3%) |
Mar 2007 | - | $9.63 M(-19.2%) |
Dec 2006 | $11.92 M(+141.4%) | $11.92 M(-16.8%) |
Sep 2006 | - | $14.33 M(-13.7%) |
Jun 2006 | - | $16.60 M(-7.2%) |
Mar 2006 | - | $17.90 M(+262.4%) |
Dec 2005 | $4.94 M | $4.94 M(-13.2%) |
Sep 2005 | - | $5.69 M(+180.8%) |
Jun 2005 | - | $2.03 M(>+9900.0%) |
Mar 2005 | - | $100.00 |
FAQ
- What is Cellectar Biosciences annual total assets?
- What is the all time high annual total assets for Cellectar Biosciences?
- What is Cellectar Biosciences annual total assets year-on-year change?
- What is Cellectar Biosciences quarterly total assets?
- What is the all time high quarterly total assets for Cellectar Biosciences?
- What is Cellectar Biosciences quarterly total assets year-on-year change?
What is Cellectar Biosciences annual total assets?
The current annual total assets of CLRB is $12.08 M
What is the all time high annual total assets for Cellectar Biosciences?
Cellectar Biosciences all-time high annual total assets is $58.66 M
What is Cellectar Biosciences annual total assets year-on-year change?
Over the past year, CLRB annual total assets has changed by -$9.51 M (-44.07%)
What is Cellectar Biosciences quarterly total assets?
The current quarterly total assets of CLRB is $37.29 M
What is the all time high quarterly total assets for Cellectar Biosciences?
Cellectar Biosciences all-time high quarterly total assets is $58.66 M
What is Cellectar Biosciences quarterly total assets year-on-year change?
Over the past year, CLRB quarterly total assets has changed by +$25.22 M (+208.83%)